Triggiani M, Granata F, Oriente A, De Marino V, Gentile M, Calabrese C, Palumbo C, Marone G
Division of Clinical Immunology and Allergy, University of Naples Federico II, Naples, Italy.
J Immunol. 2000 May 1;164(9):4908-15. doi: 10.4049/jimmunol.164.9.4908.
Secretory phospholipases A2 (sPLA2s) are a group of extracellular enzymes that release fatty acids at the sn-2 position of phospholipids. Group IIA sPLA2 has been detected in inflammatory fluids, and its plasma level is increased in inflammatory diseases. To investigate a potential mechanism of sPLA2-induced inflammation we studied the effect of group IA (from cobra venom) and group IIA (human synovial) sPLA2s on human macrophages. Both sPLA2s induced a concentration- and Ca2+-dependent, noncytotoxic release of beta-glucuronidase (16.2 +/- 2.4% and 13.1 +/- 1.5% of the total content with groups IA and IIA, respectively). Both sPLA2s also increased the rate of secretion of IL-6 and enhanced the expression of IL-6 mRNA. Preincubation of macrophages with inhibitors of the hydrolytic activity of sPLA2 or cytosolic PLA2 did not influence the release of beta-glucuronidase. Incubation of macrophages with p-aminophenyl-mannopyranoside-BSA (mp-BSA), a ligand of the mannose receptor, also resulted in beta-glucuronidase release. However, while preincubation of macrophages with mp-BSA had no effect on beta-glucuronidase release induced by group IIA sPLA2, it enhanced that induced by group IA sPLA2. A blocking Ab anti-mannose receptor inhibited both mp-BSA- and group IIA-induced beta-glucuronidase release. Taken together, these data indicate that group IA and IIA sPLA2s activate macrophages with a mechanism independent from their enzymatic activities and probably related to the activation of the mannose receptor or sPLA2-specific receptors. The secretion of enzymes and cytokines induced by sPLA2s from human macrophages may play an important role in inflammation and tissue damage associated with the release of sPLA2s.
分泌型磷脂酶A2(sPLA2s)是一组能在磷脂的sn-2位释放脂肪酸的细胞外酶。IIA组sPLA2已在炎性液体中检测到,且在炎性疾病中其血浆水平会升高。为了研究sPLA2诱导炎症的潜在机制,我们研究了IA组(来自眼镜蛇毒液)和IIA组(人滑膜)sPLA2对人巨噬细胞的影响。两种sPLA2均诱导了β-葡萄糖醛酸酶浓度和Ca2+依赖性、非细胞毒性的释放(IA组和IIA组分别为总含量的16.2±2.4%和13.1±1.5%)。两种sPLA2还提高了IL-6的分泌速率并增强了IL-6 mRNA的表达。用sPLA2或胞质型PLA2水解活性抑制剂对巨噬细胞进行预孵育,并不影响β-葡萄糖醛酸酶的释放。用甘露糖受体的配体对氨基苯基-甘露吡喃糖苷-BSA(mp-BSA)孵育巨噬细胞,也导致了β-葡萄糖醛酸酶的释放。然而,虽然用mp-BSA对巨噬细胞进行预孵育对IIA组sPLA2诱导的β-葡萄糖醛酸酶释放没有影响,但它增强了IA组sPLA2诱导的释放。抗甘露糖受体阻断抗体抑制了mp-BSA和IIA组诱导的β-葡萄糖醛酸酶释放。综上所述,这些数据表明IA组和IIA组sPLA2通过一种独立于其酶活性的机制激活巨噬细胞,且可能与甘露糖受体或sPLA2特异性受体的激活有关。人巨噬细胞中sPLA2诱导的酶和细胞因子的分泌可能在与sPLA2释放相关的炎症和组织损伤中起重要作用。